CAV2 and cancer: We also demonstrated, for the first time, that CAV2 can regulate the MiR-4723/Wnt7A signalling axis in pancreatic cancer cells by inhibiting endocytosis and promoting EMT, thereby accomplishing its pro-cancer effects.